Rating History for CONMED (CNMD) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for CNMD
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/17/2026 Matt O\'Brien Downgrade Neutral
(Overweight)		 39.00
(55.00)		 37.28
(35.34)		 -5.2% Details